Watch Connie Strasheim, author of "The Lyme Disease Survival Guide," on her new video blog!
|
|
2716 Members
24 Forums
4570 Topics
5953 Posts
Max Online: 251 @ 12/25/10 12:01 AM
|
|
|
#2492 - 11/09/07 06:16 PM
ILADS names "new" President...Dr Daniel Cameron....
|
Angls4hope
Forum Veteran
Registered: 11/29/06
Posts: 2069
|
International Lyme and Associated Diseases Society Names New President Board of Directors Elects Dr. Daniel Cameron, Epidemiology Pioneer
Press Release
http://www.emediawire.com/releases/2007/10/emw565028.htm
Bethesda, MD (PRWEB) October 30, 2007 -- The International Lyme and
Associated Diseases Society (ILADS) announced today that it has
elected Dr. Daniel Cameron to serve as the new President of the Board
for the next two years. The appointment was announced during the
annual ILADS conference that drew more than 300 attendees that
included medical practitioners and researchers who specialize in Lyme
Disease and representatives from patient advocacy groups.
Dr. Cameron is the chief author of the ILADS evidence-based medicine
practice guidelines. The ILADS treatment guidelines are based on
evidence that Lyme is a complex disease, with symptoms that can vary
significantly in patients. The ILADS guidelines are in direct conflict
with the current accepted guidelines which support a view of Lyme as a
simple disease that requires short doses of antibiotics as treatment.
"Lyme disease has become a major epidemic in this country," said Dr.
Cameron. "It is a complex and debilitating disease for many people. As
president of the board, I hope to help bring researchers and
practicing physicians together to identify better ways to diagnose and
treat Lyme."
Cameron is an attending physician at the Northern Westchester Hospital
and has served as an ILADS board member for the last six years.
Cameron has made many contributions to clinical research on Lyme
disease. He has pioneered the field of clinical epidemiology in Lyme
disease as an author of practice guidelines, analytic reviews, and
clinical trials. He continues to devote much of his research time to
improving the outcomes of Lyme disease patients.
Cameron succeeds Dr. Raphael Stricker, who has served as ILADS
president for the last two years. During his tenure, Stricker has
successfully led ILADS to a prominent position in the fight against
tick-borne diseases, passionately promoting the ILADS standard of care
for Lyme. Stricker authored the article that appeared in the July 15
issue of Clinical Infectious Diseases, one of the most prestigious
journals in the field of infectious disease and microbiology. The
article represented the first time that evidence supporting the ILADS
point of view has been published by a leading American infectious
disease journal.
Controversy Over Treatment Guidelines
According to the Centers for Disease Control and Prevention, reported
cases of Lyme disease have more than doubled in the last 15 years.
Latest statistics indicate more than 20,000 cases are reported to the
government each year. However, many experts believe the actual number
of cases is closer to 200,000.
For those patients who demonstrate classic symptoms of the disease
soon after recognizing a tick bite, such as a "bull's eye" rash and
joint pain, a short dose of antibiotics often eradicates the disease
from the body. But only 50% of Lyme patients actually recall a tick
bite. And the classic symptoms are typically experienced by only a
fraction of patients diagnosed with the disease.
ILADS treatment guidelines are based on the belief that Lyme disease
is a complex illness that is often difficult to diagnose and requires
specialized treatment based on patient symptoms and physician
judgment. Guideline highlights include:
-- Given lack of a definitive diagnostic test for Lyme disease,
laboratory results should not be used to exclude a patient from treatment.
-- Lyme disease is a clinical diagnosis and tests should be used to
support rather than supersede the physician's judgment.
-- Early use of antibiotics can prevent persistent, recurrent, and
refractory Lyme disease.
-- Duration of antibiotic therapy should be guided by the patient's
response to treatment, rather than by an arbitrary (ie, 30 day)
treatment course.
-- The practice of stopping antibiotics to allow for delayed
recovery is not recommended for persistent Lyme disease. In these
cases, it is reasonable to continue treatment for several months after
clinical and laboratory abnormalities have begun to resolve and
symptoms have disappeared.
About ILADS:
ILADS is a nonprofit, international, multidisciplinary medical
society, dedicated to the diagnosis and appropriate treatment of Lyme
and its associated diseases. ILADS promotes understanding of
tick-borne diseases through research and education and strongly
supports physicians and other health care professionals dedicated to
advancing the standard of care for Lyme and its associated diseases.
For More Information, contact:
Pam Kahl
International Lyme and Associated Diseases Society
http://www.ilads.org/
503 284-1534
|
|
Top
|
|
|
|
Moderator: LymeAngl, Angls4hope
|
|
This doctor just released the first book about Lyme written by an M.D. Learn More.
|
|
0 registered
and 45 anonymous users online.
|
|
|
New
posts in this forum since you last visited
No
new posts